Appendix RESULTS: CHAPTER 3 Table 20. Estimated indirect and inpatient costs for digestive diseases in 2019 or most recent year available, in Euros (millions), for 31 UEG member countries Estimated cost of lost Estimated cost of lost output due to digestive disease related morbidity Austria Belgium Bulgaria Croatia Czechia Denmark Finland France Germany Greece Hungary Ireland Israel Italy Latvia Lithuania Luxembourg Montenegro Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey United Kingdom (Euros, millions) 1072.9 1073.7 145.0 169.7 482.9 655.8 532.4 4276.2 7836.3 306.0 363.4 329.9 455.8 6855.6 74.9 123.9 105.0 11.0 1215.8 911.5 1343.1 305.0 454.3 146.8 228.9 134.3 2169.2 875.6 1117.2 883.4 8727.7 output due to digestive disease related premature mortality (Euros, millions) 902.9 1439.7 270.3 192.7 530.2 878.6 776.0 5605.1 11887.2 234.0 518.8 273.8 306.9 3898.6 91.8 210.4 78.7 9.4 1213.5 313.5 1962.2 484.3 987.5 178.3 327.9 169.5 2687.8 588.8 1071.5 485.2 7075.2 Estimated cost of inpatient health service delivery for digestive diseases (Euros, millions) 830.5 733.0 86.1 63.4 345.9 300.2 228.4 3151.6 7461.6 293.8 149.8 250.1 190.0 2322.7 28.7 47.3 77.0 3.5 542.0 451.2 528.2 213.6 259.5 36.9 130.8 57.5 1794.2 429.2 876.0 722.8 2658.7 Inpatient data for 2019 except for the following: Denmark 2016; Finland 2018; Germany 2018; Greece 2015; Luxembourg 2016; Turkey 2018; United Kingdom 2018. White Book 2: Part 1 199